Listen in the first Tuesday of every month when we talk with Leaders in LifeSciences. Each episode of Life Sphere will feature a conversation with thought leaders across a range of skills and disciplines. The guest line-up for season one includes drug commercialization, scientists, marketing and PR, analytics, technologists, Acumen's own in-house experts and more. Through these conversations, Life Sphere will explore industry trends, must-have tools, careers, new skills, as well as (and most importantly!) demonstrate the impact life sciences has on each of us. Guests will share their unique take on the industry, including career advice, experiences, how to overcome hurdles, and more.
A Fourth Industrial Revolution: Life Sciences Real Estate and Digital Transformation how a straight line is not always the best path with Nancy J Kelley JD, MPP
Nancy J Kelley, JD, is a nationally recognized executive who has driven key strategic initiatives in science and medicine for over 20 years. She has a deep understanding of the healthcare, life science and research fields and has in-depth knowledge of the related legal, business, government, non-profit and academic sectors in New York City and across the country.
Ms. Kelley's prior leadership history includes work in scientific institutions, life science companies and life science real estate development. She is a Founding Member of NYC Builds BIO+. She is a member of the Founding Leadership team of the international scientific project GP-write and the associated Center of Excellence for Engineering Biology, and helped to launch the Biodesign Challenge. Ms. Kelley was the Founding Executive Director of the New York Genome Center and a lead executive in the development of the East River Science Park (now, Alexandria Life Science Center) in Manhattan. She has overseen major development projects for clients such as Harvard's McLean Hospital, NIH, Johns Hopkins, and MIT.
In this episode Kathy and Nancy discuss Life Sciences Real Estate, Digital Transformation, the Fourth Industrial Revolution, and how a straight line is not always the best path.
Building a World Class Biotech Hub with Audrey Greenberg
Audrey Greenberg is the Co-founder, Chief Business Officer and Board Member of The Center for Breakthrough Medicines. Audrey’s area of expertise is in capital structure, business formation, acquisitions, strategic planning and tactical execution. Audrey’s deep industry experience includes biotechnology, real estate, pharma services, and financial services.Prior to starting The Center for Breakthrough Medicines, Audrey spent several years in investment banking, public accounting and private equity having worked at some of the largest asset managers in the world with AUM exceeding $100 billion. Audrey is passionate about supporting her community and serves on several non-profit boards including the King of Prussia Business District and is currently an Emissary for Select Greater Philadelphia, a division of the Philadelphia Chamber of Commerce responsible for attracting business to Greater Philadelphia.Audrey was recently selected by Philadelphia Magazine as one of the top trailblazers in Biotech and was featured on the cover of Main Line Today’s Power Women edition. Audrey has an MBA from The Wharton School and is a registered CPA in Illinois.
In this episode Kathy talks with Audrey about creating a world class Biotech Hub in Cellicon Valley, Startup Tactics and the Future of Medicine
Talking Quality 4.0 at Interphex with Oxana Pickeral: President & CEO, Sparta Systems
Oxana K. Pickeral, Ph.D., MBA, is an accomplished technology executive with over 25 years of experience in healthcare and the life sciences, spanning from her work on the Human Genome Project to bioinformatics R&D and clinical trials innovation, to advanced analytics and patient engagement technologies. Prior to becoming the President and CEO of Sparta Systems, Dr. Pickeral was the Global Segment Leader for Healthcare and Life Sciences at AWS where she oversaw the AWS portfolio of technology and consulting partners with specialized offerings and innovative technology tools relevant to BioPharma, Genomics, Medical Device, Payers, Providers, and Agriculture, world-wide. Dr. Pickeral holds a Ph.D. in Human Genetics and an MBA in Finance from Johns Hopkins University.
In this episode Kathy caught up with Dr. Oxana K. Pickeral while she was at Interphex to talk about Quality 4.0, Digital Transformation, Connected Life Sciences and improving patient outcomes.
Bringing Innovation to patients through Launch Excellence with Digital Technology, Innovation, Real World Data a conversation with Hettie Stroebel Founder & CEO
Hettie is a former Merck & Co., Inc executive with 25+years’ experience in Life Sciences. Her focus is on global strategic marketing and commercialization creating value for patients, providers, and payers. She led seven product launches, all exceeding profitability targets in major global markets. Her impact on running business units ranges from $100 Million to $1Billion per year.
Working as a volunteer with the non-profit organization, Women in Bio, she leads the US East Coast, Women in Bio Founders Forum, and Chair the Programming Committee. The Founders Forum supports the development and acceleration of success of female founders, especially first-time founders (early-stage and seed-stage startups), and their ventures via peer-to-peer interaction, ultimately attempting to shorten learning curves.
Her passion comes from understanding business, leadership, team dynamics, and most importantly how to deliver value.
In this episode Kathy talks with Hettie Stroebel about how companies can shorten the timeline to Commercialization and achieve Launch Excellence with Digital Technology, Innovation, Real World Data and differentiated Target Product Profiles